IL148469A0 - Apoptin-associating protein - Google Patents

Apoptin-associating protein

Info

Publication number
IL148469A0
IL148469A0 IL14846900A IL14846900A IL148469A0 IL 148469 A0 IL148469 A0 IL 148469A0 IL 14846900 A IL14846900 A IL 14846900A IL 14846900 A IL14846900 A IL 14846900A IL 148469 A0 IL148469 A0 IL 148469A0
Authority
IL
Israel
Prior art keywords
apoptin
associating protein
novel therapeutic
novel
apoptosis
Prior art date
Application number
IL14846900A
Other languages
English (en)
Original Assignee
Leadd Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99202858A external-priority patent/EP1081226A1/de
Priority claimed from EP99203465A external-priority patent/EP1108785A1/de
Application filed by Leadd Bv filed Critical Leadd Bv
Publication of IL148469A0 publication Critical patent/IL148469A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14846900A 1999-09-02 2000-09-01 Apoptin-associating protein IL148469A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99202858A EP1081226A1 (de) 1999-09-02 1999-09-02 Apoptin-bindendes Protein
EP99203465A EP1108785A1 (de) 1999-10-21 1999-10-21 Apoptin-verbundenes Protein
PCT/NL2000/000612 WO2001016165A2 (en) 1999-09-02 2000-09-01 Apoptin-associating protein

Publications (1)

Publication Number Publication Date
IL148469A0 true IL148469A0 (en) 2002-09-12

Family

ID=26153361

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14846900A IL148469A0 (en) 1999-09-02 2000-09-01 Apoptin-associating protein
IL148469A IL148469A (en) 1999-09-02 2002-03-03 Apoptin-associating protein, a method for its production and use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL148469A IL148469A (en) 1999-09-02 2002-03-03 Apoptin-associating protein, a method for its production and use thereof

Country Status (20)

Country Link
US (2) US7317096B1 (de)
EP (1) EP1083224B1 (de)
JP (1) JP2003510030A (de)
CN (1) CN100513565C (de)
AT (1) ATE347597T1 (de)
AU (1) AU781127B2 (de)
BR (1) BR0013743A (de)
CA (1) CA2383784A1 (de)
CY (1) CY1106355T1 (de)
DE (1) DE60032201T2 (de)
DK (1) DK1083224T3 (de)
EA (1) EA005933B1 (de)
ES (1) ES2277815T3 (de)
HU (1) HUP0202688A2 (de)
IL (2) IL148469A0 (de)
NO (1) NO20021067L (de)
NZ (1) NZ517740A (de)
PL (1) PL204275B1 (de)
PT (1) PT1083224E (de)
WO (1) WO2001016165A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150134A0 (en) * 1999-12-10 2002-12-01 Leadd Bv Apoptin-associating protein
WO2009126920A2 (en) 2008-04-11 2009-10-15 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
WO2011100428A2 (en) * 2010-02-10 2011-08-18 The Uab Research Foundation Compositions for improving bone mass

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
ATE305514T1 (de) 1994-12-22 2005-10-15 Novartis Pharma Gmbh Nukleäre protein serin/threoninkinasen
ES2200065T3 (es) * 1995-06-07 2004-03-01 Leadd B.V. Utilizacion de apoptina.
CA2283299A1 (en) 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
SK286235B6 (sk) * 1997-08-12 2008-06-06 Leadd B. V. Spôsob zisťovania transformačnej schopnosti látky, spôsob zisťovania predispozície buniek stať sa nádorovými bunkami, použitie nukleovej kyseliny a diagnostická súprava
EP0924296A3 (de) * 1997-12-03 2001-08-01 Leadd B.V. Verfahren un Mittteln für die Induktion von Apoptosis durch Interferenz in RNS-Prozessierung
EP0927757A1 (de) * 1997-12-03 1999-07-07 Leadd B.V. Verfahren und Mitteln um Apoptose zu induzieren durch Interferenz mit Bip-ähnliche Proteine
EP0921192A1 (de) * 1997-12-03 1999-06-09 Leadd B.V. Molekulen interagierend mit Apoptin
US20030105315A1 (en) 1998-04-09 2003-06-05 Metagen Pharmaceuticals Gmbh Human nucleic acid sequences from ovarian tumor tissue
JP2002513554A (ja) * 1998-05-05 2002-05-14 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト転写調節分子
EP1111045A3 (de) 1999-12-10 2001-09-19 Leadd B.V. Apoptin-bindendes Protein
IL150134A0 (en) 1999-12-10 2002-12-01 Leadd Bv Apoptin-associating protein
EP1106691A1 (de) 1999-12-10 2001-06-13 Leadd B.V. Apoptin verbundenes Protein
AU3422801A (en) 2000-01-17 2001-07-31 Leadd B.V. Apoptin-associating protein
EP1138765A1 (de) 2000-03-27 2001-10-04 Leadd B.V. Apoptin verbundene Proteine AAP-5 und AAP-6

Also Published As

Publication number Publication date
DE60032201T2 (de) 2007-09-20
DE60032201D1 (de) 2007-01-18
DK1083224T3 (da) 2007-04-10
IL148469A (en) 2009-02-11
PL204275B1 (pl) 2009-12-31
HUP0202688A2 (en) 2002-12-28
CN100513565C (zh) 2009-07-15
EA005933B1 (ru) 2005-08-25
AU781127B2 (en) 2005-05-05
ATE347597T1 (de) 2006-12-15
NZ517740A (en) 2003-09-26
NO20021067L (no) 2002-05-02
EA200200321A1 (ru) 2002-08-29
NO20021067D0 (no) 2002-03-04
BR0013743A (pt) 2005-01-11
WO2001016165A2 (en) 2001-03-08
PL354285A1 (en) 2003-12-29
JP2003510030A (ja) 2003-03-18
CN1387569A (zh) 2002-12-25
WO2001016165A3 (en) 2001-09-20
AU7324200A (en) 2001-03-26
ES2277815T3 (es) 2007-08-01
PT1083224E (pt) 2007-03-30
CA2383784A1 (en) 2001-03-08
EP1083224B1 (de) 2006-12-06
CY1106355T1 (el) 2011-10-12
US20080176231A1 (en) 2008-07-24
EP1083224A3 (de) 2001-04-25
US7317096B1 (en) 2008-01-08
US7767790B2 (en) 2010-08-03
EP1083224A2 (de) 2001-03-14

Similar Documents

Publication Publication Date Title
PL339860A1 (en) Methods of modulating the action of serine/threonine protein kinase by means of compounds based on 5-azaquinoxaline
ZA988797B (en) Methods of modulating serine/threonine protein kinase function with azabenzimidazole-based compounds.
DK0713529T3 (da) Vækst-/differentieringsfaktor af TGF-beta-familien
WO2002057303A3 (en) Protein-protein interactions between shigella flexneri polypeptides and mammalian polypeptides
DE60215848D1 (de) 1,2,4-thiadiazolverbindungen als melanocortinrezeptor-modulatoren
WO2002065134A3 (en) Modulators of p53-p300 interactions and screening methods therefor
AU2001260880A1 (en) Pharmaceutical compounds for treating copd
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
AU1559501A (en) Apoptosis inducing proteinaceous substance
IL148469A0 (en) Apoptin-associating protein
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
EP0990703A4 (de) Neues polypeptid, dafür kodierende dna und deren verwendungen
WO2001072825A3 (en) Apoptin-associating protein
AU2205099A (en) Chimeric proteins for the treatment of diabetes
WO2001042461A3 (en) Apoptin-associating protein
EP1111045A3 (de) Apoptin-bindendes Protein
AU2002257067A1 (en) Tsg101-gag interaction and use thereof
WO2001053351A3 (en) Apoptin bindendes protein
DE60038955D1 (de) AN DER OBERFLÄCHE VON KARZINOMZELLEN LOKALISIERTES COLLIGIN/HsP47
EP1138768A3 (de) Apoptin-bindendes Protein AAP-5
EP1118662A3 (de) Apoptin bindendes Protein
MXPA03007990A (es) Uso de la proteina histidina fosfatasa.
WO2003060067A3 (en) P85-alpha nucleic acids, polypeptides and related methods
AU3744100A (en) Bicyclo(3.3.1)nonenes useful for the treatment of diabetes
AU2003249999A1 (en) 1,4,7,10-tetraazacyclododecanes as modulators of the guanine-binding protein for treating tumours

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed